Ribocure Pharmaceuticals AB
Ribocure Pharmaceuticals AB
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vortosiran for VTE Prevention | Embolism, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cancer, cardiovascular disorder, disease, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism | Not yet recruiting | Phase 2 | 2026-09-30 | NCT07850453 | |
| Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic disease | Recruiting | Phase 2 | 2026-09-10 | NCT06797401 | |
| Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D | Chronic Disease, Digestive System Diseases, Disease Attributes, Hepatitis D, Chronic, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, hepatitis, hepatitis D virus infection, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 | 2026-02-03 | NCT06649266 |